Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
Code effective Oct 01, 2022
HCPCS Section
Temporary Codes for Use with Outpatient Prospective Payment System
C9096 is a valid 2026 HCPCS code meaning Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram or (Inj, releuko, 1 mcg) for short. HCPCS C9096 has been effective since 10/01/2022 and applies to Medical care.
|
HCPCS Level II Code Section C - Temporary Codes for Use with Outpatient Prospective Payment System |
|
| HCPCS Code | C9096 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Pricing indicator |
53 - Statute
|
| Multiple pricing indicator |
A - Not applicable as HCPCS priced under one methodology
|
| Coverage code | C - Carrier judgment |
| BETOS2 code | O1E - Other drugs |
| HCPCS Action code | N - No maintenance for this code |
| Type of service | 1 - Medical care |
| Effective date | Effective Oct 01, 2022 |
| Date added | Added Jul 01, 2022 |
| Termination date | Sep 30, 2022 |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/24/2026
CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.